Clinical impact of dose reductions and interruptions of second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukaemia
Fabio P. S. Santos; Hagop Kantarjian; Carmen Fava; Susan O’Brien; Guillermo Garcia-Manero; Farhad Ravandi; William Wierda; Deborah Thomas; Jianquin Shan; Jorge Cortes
- 作者Fabio P. S. Santos; Hagop Kantarjian; Carmen Fava; Susan O’Brien; Guillermo Garcia-Manero; Farhad Ravandi; William Wierda; Deborah Thomas; Jianquin Shan; Jorge Cortes
- 卷第150卷
- 期第3期
- 印刷ISSN0007-1048
- 电子ISSN1365-2141
- 文件大小202.35KB
- 发表时间2010
- DOI10.1111/j.1365-2141.2010.08245.x
- 页码303-312